[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0091-6749&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=00034937230000
6Background: Omalizumab is a recombinant anti-immunoglobulin E (IgE) antibody used in the treatment ...
Chronic spontaneous urticaria (CSU) is characterized by the occurrence of hives, angio-oedema or bot...
Chronic spontaneous urticaria (CSU) is characterized by the occurrence of hives, angio-oedema or bot...
Abstract The introduction of omalizumab to the management of chronic spontaneous urti...
Omalizumab is an IgG-type monoclonal antibody against IgE and is the current third line approach to ...
Chronic spontaneous urticaria (CSU) is a debilitating condition that affects individuals for an exte...
Chronic spontaneous urticaria (CSU) is a skin disease characterised by wheal appearance, swelling, i...
Abstract Chronic spontaneous urticaria (CSU) is a debilitating inflammatory disorder of the skin, ch...
Chronic spontaneous urticaria (CSU) is a common skin disease. Many patients with CSU do not have a r...
This systematic review evaluates the efficacy and safety of omalizumab for chronic spontaneous urtic...
Background: Chronic Spontaneous Urticaria (CSU) is a disease characterized by the onset of wheals an...
I have read the article titled, ''Efficacy and safety of omalizumab against chronic spontaneous urti...
Chronic spontaneous urticaria (CSU) is a skin disease that predominantly affects adults, especially ...
Omalizumab is an effective treatment for patients with chronic spontaneous urticaria (CSU). In routi...
Omalizumab is a recombinant humanized anti-IgE monoclonal antibody, approved for patients affected ...
6Background: Omalizumab is a recombinant anti-immunoglobulin E (IgE) antibody used in the treatment ...
Chronic spontaneous urticaria (CSU) is characterized by the occurrence of hives, angio-oedema or bot...
Chronic spontaneous urticaria (CSU) is characterized by the occurrence of hives, angio-oedema or bot...
Abstract The introduction of omalizumab to the management of chronic spontaneous urti...
Omalizumab is an IgG-type monoclonal antibody against IgE and is the current third line approach to ...
Chronic spontaneous urticaria (CSU) is a debilitating condition that affects individuals for an exte...
Chronic spontaneous urticaria (CSU) is a skin disease characterised by wheal appearance, swelling, i...
Abstract Chronic spontaneous urticaria (CSU) is a debilitating inflammatory disorder of the skin, ch...
Chronic spontaneous urticaria (CSU) is a common skin disease. Many patients with CSU do not have a r...
This systematic review evaluates the efficacy and safety of omalizumab for chronic spontaneous urtic...
Background: Chronic Spontaneous Urticaria (CSU) is a disease characterized by the onset of wheals an...
I have read the article titled, ''Efficacy and safety of omalizumab against chronic spontaneous urti...
Chronic spontaneous urticaria (CSU) is a skin disease that predominantly affects adults, especially ...
Omalizumab is an effective treatment for patients with chronic spontaneous urticaria (CSU). In routi...
Omalizumab is a recombinant humanized anti-IgE monoclonal antibody, approved for patients affected ...
6Background: Omalizumab is a recombinant anti-immunoglobulin E (IgE) antibody used in the treatment ...
Chronic spontaneous urticaria (CSU) is characterized by the occurrence of hives, angio-oedema or bot...
Chronic spontaneous urticaria (CSU) is characterized by the occurrence of hives, angio-oedema or bot...